Tanner M. Johanns

Washington University in St. Louis — United States

Immunology and Microbiology · Life Sciences

29h-index3.6kcitations825works0.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(626), Cancer Research and Treatments(391), vaccines and immunoinformatics approaches(367), RNA Interference and Gene Delivery(317), Cancer Immunotherapy and Biomarkers(131)

Publications825 total

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial
Nature Communications·2026Open Access
Supplementary Figure S6 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Figure S8 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S3 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Figure S7 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S10 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S4 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S9 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S6 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S8 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Figure S9 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S2 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S1 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S7 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
Supplementary Table S5 from Integrating Multisector Molecular Characterization into Personalized Peptide Vaccine Design for Patients with Newly Diagnosed Glioblastoma
2026Open Access
ImmunoNX: a robust bioinformatics workflow to support personalized neoantigen vaccine trials.
PubMed·2025
Supplementary Data from The Conventional Dendritic Cell 1 Subset Primes CD8<sup>+</sup> T Cells and Traffics Tumor Antigen to Drive Antitumor Immunity in the Brain
2025Open Access
CTIM-33. PERSONALIZED MULTIVALENT DNA VACCINATION SAFELY INDUCES BROAD NEOANTIGEN-SPECIFIC T CELL RESPONSES IN NEWLY DIAGNOSED MGMT UNMETHYLATED GLIOBLASTOMA IN A CLINICALLY RELEVANT TIME SCALE
Neuro-Oncology·2025Open Access
Metabolic Shift Mirrors GBM Immunity to Anti-PD-L1 Immunotherapy: A Deuterium MRS Study
Molecular Imaging and Biology·2025Open Access
Mapping CD4 <sup>+</sup> T Cell Landscapes in Glioblastoma Reveals Effectors and Bystanders
2025Open Access
page 1 of 42Next →

Frequent Co-authors

Gavin P. Dunn(25), Albert H. Kim(11), Jiayi Huang(9), James M. Ertelt(8), Jared H. Rowe(8), Sing Sing Way(8), George Ansstas(7), Dale K. Kobayashi(7), Maximilian O. Schaettler(7), Christopher A. Miller(6), Sonika Dahiya(6), Alexandra J. Livingstone(6), Jian Campian(6), Michael R. Chicoine(6), Elaine R. Mardis(5), Diane E. Bender(5), Connor J. Liu(5), Jay A. Bowman-Kirigin(5), Eric C. Leuthardt(5), Anthony Z. Wang(4)